ABANZA Secures FDA 510(k) Clearance for QuadLock(TM) Fixation System for ACL Reconstruction

ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...
WLOX

Singing River Health System offering new, innovative ACL treatment

GULFPORT, Miss. (WLOX) - Singing River Health System is the first in Mississippi to offer innovative Bridge Enhanced ACL Repair, or BEAR Implants to treat ACL tears. Every year, approximately 400,000 ...
Healio

Abanza receives FDA 510(k) clearance of implantable ACL fixation system

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Abanza Tecnomed has announced FDA 510(k) clearance of ...
Healio

Delayed ACL reconstruction may be acceptable in less active, less injury-prone adults

Please provide your email address to receive an email when new articles are posted on . ACL reconstruction delayed longer than 8 weeks from injury did not increase new meniscus tears in adults.
Orthopedics This Week

ABANZA Secures FDA 510(k) Clearance for QuadLock™ Fixation System for ACL Reconstruction

ABANZA’s QuadLock™ delivers market-leading fixation strength with over a 500% reduction in cyclic displacement compared to conventional fixation methods. QuadLock™ is designed to securely fixate ...